GR3005934T3 - - Google Patents

Info

Publication number
GR3005934T3
GR3005934T3 GR920402254T GR920402254T GR3005934T3 GR 3005934 T3 GR3005934 T3 GR 3005934T3 GR 920402254 T GR920402254 T GR 920402254T GR 920402254 T GR920402254 T GR 920402254T GR 3005934 T3 GR3005934 T3 GR 3005934T3
Authority
GR
Greece
Application number
GR920402254T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005934T3 publication Critical patent/GR3005934T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
GR920402254T 1986-04-30 1992-10-12 GR3005934T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10155286 1986-04-30
JP31509086 1986-12-31

Publications (1)

Publication Number Publication Date
GR3005934T3 true GR3005934T3 (cg-RX-API-DMAC10.html) 1993-06-07

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402254T GR3005934T3 (cg-RX-API-DMAC10.html) 1986-04-30 1992-10-12

Country Status (18)

Country Link
US (1) US4870074A (cg-RX-API-DMAC10.html)
EP (1) EP0243959B1 (cg-RX-API-DMAC10.html)
KR (1) KR870010030A (cg-RX-API-DMAC10.html)
AR (1) AR242953A1 (cg-RX-API-DMAC10.html)
AU (1) AU592177B2 (cg-RX-API-DMAC10.html)
CA (1) CA1291135C (cg-RX-API-DMAC10.html)
CZ (1) CZ284687B6 (cg-RX-API-DMAC10.html)
DE (1) DE3781195T2 (cg-RX-API-DMAC10.html)
DK (1) DK175281B1 (cg-RX-API-DMAC10.html)
ES (1) ES2043617T3 (cg-RX-API-DMAC10.html)
FI (1) FI87776C (cg-RX-API-DMAC10.html)
GR (1) GR3005934T3 (cg-RX-API-DMAC10.html)
HK (1) HK18194A (cg-RX-API-DMAC10.html)
HU (1) HU198193B (cg-RX-API-DMAC10.html)
NZ (1) NZ220120A (cg-RX-API-DMAC10.html)
PH (1) PH24049A (cg-RX-API-DMAC10.html)
SK (1) SK289787A3 (cg-RX-API-DMAC10.html)
SU (1) SU1597101A3 (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
TW243449B (cg-RX-API-DMAC10.html) * 1991-02-15 1995-03-21 Hokuriku Pharmaceutical
KR970702247A (ko) * 1994-03-30 1997-05-13 고야 마사시 벤조산 화합물 및 이들의 약제로서의 용도(benzoic acid compound and use thereof as medicine)
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
JPH11505815A (ja) * 1995-05-23 1999-05-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ (2−モルホリニルメチル)ベンズアミン誘導体
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
AR035205A1 (es) * 2000-09-29 2004-05-05 Glaxo Group Ltd Compuestos utiles en el tratamiento de enfermedades inflamatorias, proceso para su preparacion, intermediarios y composiciones farmaceuticas
EP1353918B1 (en) * 2000-11-28 2005-01-12 Smithkline Beecham Plc Morpholine derivatives as antagonists of orexin receptors
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
HUP0402611A2 (hu) * 2001-10-08 2005-07-28 Sun Pharmaceutical Industries Limited Görcsoldó hatóanyag szakaszos leadására szolgáló rendszer
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
KR20060126688A (ko) * 2003-12-09 2006-12-08 다이닛본 스미토모 세이야꾸 가부시끼가이샤 약물-함유 입자 및 그 입자를 함유하는 고형 제제
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
CA2551686C (en) 2004-01-07 2014-09-23 Ian Irwin Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
CA2579207C (en) 2004-09-08 2011-10-18 Mitsubishi Pharma Corporation Morpholine compound
EP1904481B1 (en) 2005-06-23 2016-02-17 Array Biopharma, Inc. Process for preparing benzimidazole compounds
EP1919909B1 (en) * 2005-08-31 2013-08-21 Armetheon, Inc. Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders
CA2633042A1 (en) * 2005-12-20 2007-07-05 Merck & Co., Inc. Niacin receptor agonists, compositions containing such compounds and methods of treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
WO2007149929A1 (en) * 2006-06-23 2007-12-27 Aryx Therapeutics, Inc. Piperidine derivatives for the treatment of gastrointestinal and cns disorders
US7528131B2 (en) 2007-04-19 2009-05-05 Concert Pharmaceuticals Inc. Substituted morpholinyl compounds
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
US20110053942A1 (en) 2008-02-13 2011-03-03 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
CN102548542B (zh) 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
ES2587304T3 (es) 2011-02-25 2016-10-21 Yuhan Corporation Derivados de diaminopirimidina y procedimientos para la preparación de los mismos
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体
CN114591260B (zh) * 2020-12-05 2025-07-11 鲁南制药集团股份有限公司 一种莫沙必利有机酸盐
CN119241464A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法
CN119241463A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Al又はAl合金の気相ろう付法

Also Published As

Publication number Publication date
SK279058B6 (sk) 1998-06-03
HK18194A (en) 1994-03-11
EP0243959B1 (en) 1992-08-19
CZ289787A3 (cs) 1998-11-11
EP0243959A1 (en) 1987-11-04
DK218787D0 (da) 1987-04-29
FI871828A7 (fi) 1987-10-31
AU592177B2 (en) 1990-01-04
FI87776B (fi) 1992-11-13
HU198193B (en) 1989-08-28
US4870074A (en) 1989-09-26
PH24049A (en) 1990-03-05
DK218787A (da) 1987-10-31
NZ220120A (en) 1989-06-28
HUT45514A (en) 1988-07-28
SU1597101A3 (ru) 1990-09-30
ES2043617T3 (es) 1994-01-01
SK289787A3 (en) 1998-06-03
DE3781195T2 (de) 1993-02-18
FI87776C (fi) 1993-02-25
DE3781195D1 (de) 1992-09-24
FI871828A0 (fi) 1987-04-27
KR870010030A (ko) 1987-11-30
AU7227587A (en) 1987-11-05
CA1291135C (en) 1991-10-22
DK175281B1 (da) 2004-08-09
CZ284687B6 (cs) 1999-02-17
AR242953A1 (es) 1993-06-30

Similar Documents

Publication Publication Date Title
IN168414B (cg-RX-API-DMAC10.html)
IN171369B (cg-RX-API-DMAC10.html)
AU7131891A (cg-RX-API-DMAC10.html)
IN171245B (cg-RX-API-DMAC10.html)
IN168296B (cg-RX-API-DMAC10.html)
IN169406B (cg-RX-API-DMAC10.html)
AU7354491A (cg-RX-API-DMAC10.html)
CH669517B (cg-RX-API-DMAC10.html)
AU5644686A (cg-RX-API-DMAC10.html)
AU5724586A (cg-RX-API-DMAC10.html)
AU6019186A (cg-RX-API-DMAC10.html)
AU5614386A (cg-RX-API-DMAC10.html)
AU5480786A (cg-RX-API-DMAC10.html)
AU5745586A (cg-RX-API-DMAC10.html)
AU4375585A (cg-RX-API-DMAC10.html)
AU5257190A (cg-RX-API-DMAC10.html)
AU4910985A (cg-RX-API-DMAC10.html)
AU5783386A (cg-RX-API-DMAC10.html)
AU5173485A (cg-RX-API-DMAC10.html)
AU5703286A (cg-RX-API-DMAC10.html)
AU5857886A (cg-RX-API-DMAC10.html)
AU5655786A (cg-RX-API-DMAC10.html)
AU5348186A (cg-RX-API-DMAC10.html)
AU6011386A (cg-RX-API-DMAC10.html)
AU5227086A (cg-RX-API-DMAC10.html)